# A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

> **NCT06656039** · — · COMPLETED · sponsor: **RenJi Hospital** · enrollment: 1200 (actual)

## Conditions studied

- Renal Cell Carcinoma, Clear Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06656039
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2024-10-10
- **Final completion:** 2024-10-10
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2024-10-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06656039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06656039, "A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT06656039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*